| ²é¿´: 1362 | »Ø¸´: 6 | ||
landarylauÌú³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ËÄܰïÎÒ¿´ÏÂͶ¸å»Ø¸´ÎÒÊÇʲôÒâ˼°¡£¿ÎÒÖ×ô¿´²»¶®°¡£¿
|
|
Õâ¸ö»Ø¸´µ½µ×ÎÒÄܲ»ÄܼÌÐøÍ¶Õâ¸öÔÓÖ¾°¡£¿ Thank you very much for submitting your manuscript for publication in Biochemical Pharmacology. All articles are first screened by an appropriate editor to ensure the topic is of general interest to our readers, that only purified chemicals of known structure are examined in the study, and to judge the potential impact of the findings relative to those described in other manuscripts under consideration. Following this initial review the submissions are prioritized. Those ranked highest are sent to experts in the field who review the report and render written judgments with regard to experimental design, the method of data acquisition, data analyses and interpretation. The purpose of this correspondence is to inform you that your manuscript did not receive a priority sufficient to qualify for further review. Accordingly, it will receive no further consideration for publication in the journal. I certainly appreciate being given the opportunity to publish this work, and look forward to receiving future submissions from you and your group. |
» ²ÂÄãϲ»¶
ÍÁľˮÀûר˶276·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
0703»¯Ñ§µ÷¼Á 348·Ö
ÒѾÓÐ4È˻ظ´
ÉúÎïѧÇóµ÷¼Á Ò»Ö¾Ô¸»¦9£¬326·Ö
ÒѾÓÐ4È˻ظ´
0703µ÷¼Á£¬Ò»Ö¾Ô¸Ìì½ò´óѧ319·Ö
ÒѾÓÐ16È˻ظ´
Ò»Ö¾Ô¸ÄϿƴóÉúÎïѧ297·Ö£¬Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ5È˻ظ´
080500Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ÉúÎïÓëÒ½Ò©Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ9È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
»Ø¸´Éó¸åÈËÓÐÁ½¸öÎÊÌ⣬¶àл´ó¼Ò°ïÎÒ¿´¿´ÎÒÔõô»Ø¸´£¬Ð»Ð»£¡
ÒѾÓÐ10È˻ظ´
Çë½ÌͶ¸åÒªÇóÀïÕâµÄÒ»¶Î»°ÊÇʲôÒâ˼£¬Ð»Ð»£¡
ÒѾÓÐ3È˻ظ´
Ͷ¸åphysica bÆß¸öÔ´߸åºóÊÕµ½»Ø¸´£¬´ó¼Ò°ïÎÒ¿´¿´Ôõô°ì¡£
ÒѾÓÐ9È˻ظ´
Çë°ïæ¿´¿´Éó¸åÈËдµÄÉó¸åÒâ¼ûÊÇʲôÒâ˼°¡£¿
ÒѾÓÐ8È˻ظ´
ÎÄÕÂÖÕÓÚÓлظ´ÁË£¬Çó´óÉñ˵˵ÊÇʲôÒâ˼£¬ÎÒ¸ÃÔõô°ì£¿£¿£¿¼±¼±¼±¼±¼±¼±°¡£¡£¡£¡
ÒѾÓÐ17È˻ظ´
¿´²»¶®Ê²Ã´Òâ˼°¡
ÒѾÓÐ21È˻ظ´
ËÄܰïÎÒ¿´¿´Õâ¸ö±à¼ÊÇʲôÒâ˼°¡£¿¿´²»¶®ÕâÀÏÍâµÄ×Ö°¡
ÒѾÓÐ6È˻ظ´
¸øActa E Ͷ¸å£¬»ã¿îÎÊÌ⣬±à¼ËµÉÙÁË15ÃÀÔª£¿Ê²Ã´Òâ˼°¡£¿
ÒѾÓÐ14È˻ظ´
Âé·³´ó¼Ò°ïÎÒ¿´¿´Éó¸åÈËʲôÒâ˼£¨ÅäºÏÎï»ò½ðÊôÓлú£©
ÒѾÓÐ4È˻ظ´
ÕâÖÖÉó¸åÒâ¼ûÊÇʲôÒâ˼°¡£¿Ôõô»Ø¸´ºÃŶ
ÒѾÓÐ41È˻ظ´
Çë¸ßÊÖ°ïÎÒ¿´¿´Éó¸åÈ˵ÄÒâ¼û£¬ÆäÖÐÒ»¾ä»°£¬ÎÒÔõôҲ¿´²»¶®
ÒѾÓÐ4È˻ظ´
ÂÛÎÄÐ޻غó±à¼¸ø³öÈçÏÂÒâ¼û£¬ÓÐЩ¿´²»¶®Ê²Ã´Òâ˼£¬Ö¸¸ßÈËÖ¸µã
ÒѾÓÐ25È˻ظ´
Çó½âͶ¸å£¨Õñ¶¯Óë³å»÷£©µÄÓʼþ»Ø¸´£¬´ó¼Ò°ïÎÒ¿´Õâ¸öÊÇɶÒâ˼£¬Ð»Ð»¡£
ÒѾÓÐ8È˻ظ´
ÓÐËÄܰïÎÒ¿´ÏÂÎҵIJâÐò·åͼЧ¹ûÈçºÎ
ÒѾÓÐ12È˻ظ´
Çë´ó¼Ò°ïÎÒ¿´¿´Ôõô»Ø¸´ÕâÑùµÄproof,ÔÚÏߵȡ£¼±£¡
ÒѾÓÐ5È˻ظ´
Éó¸åÒâ¼û»Ø¸´£¨¸ñʽ·½ÃæµÄ£©£¬ººÓï´ó¸ÅÒâ˼ÒѾд³öÀ´£¬Çó·Òë
ÒѾÓÐ5È˻ظ´
±à¼¸ö»Ø¸´µÄÐÅÊÇʲôÒâ˼°¡£¿
ÒѾÓÐ7È˻ظ´
ÆÀÉóÈ˵ÄÒ»ÌõÒâ¼û¿´²»¶®£¬Çë´ó¼Ò°ïæ¿´¿´ÊÇʲôÒâ˼°¡
ÒѾÓÐ5È˻ظ´
AOµÄÉó¸å״̬¿´²»¶®£¬ÄܰïÎÒ½âÊÍÒ»ÏÂÂð£¿
ÒѾÓÐ9È˻ظ´
JPCC »Ø¸´ÁË £¬ÈçÏ£¬ÈÃÎÒÑ¡±à¼£¬Çë´óÏÀ¿´¿´ÊÇʲôÒâ˼£¿
ÒѾÓÐ18È˻ظ´
ÂÛÎÄ״̬ÒѼÓã¬ÁÐÈë´ý±à¸åʲôÒâ˼£¿
ÒѾÓÐ4È˻ظ´
ÇëÎÊÕâ¸öÉó¸å»Ø¸´ÊÇʲôÒâ˼£¿
ÒѾÓÐ15È˻ظ´
´ó¼Ò°ïÎÒ¿´¿´±à¼ÈÃÎÒ¸Éʲô
ÒѾÓÐ13È˻ظ´
¡¾ÇóÖú¡¿ÄÄλ¸ßÈ˽²Ò»ÏÂÒÅ´«Ë㷨ɶÒâ˼£¿Êé±¾¿´²»¶®°¡£¡
ÒѾÓÐ6È˻ظ´
marineman
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
°®°ËØÔ°®Éú»î
- Ó¦Öú: 486 (˶ʿ)
- ½ð±Ò: 26063.4
- É¢½ð: 7934
- ºì»¨: 36
- ɳ·¢: 1
- Ìû×Ó: 7787
- ÔÚÏß: 279.7Сʱ
- ³æºÅ: 255556
- ×¢²á: 2006-05-28
- ÐÔ±ð: GG
- רҵ: µÈÀë×ÓÌåÎïÀí
2Â¥2013-08-02 13:47:19
lkqzpp
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 57 (³õÖÐÉú)
- ½ð±Ò: 53.4
- É¢½ð: 200
- ºì»¨: 3
- Ìû×Ó: 201
- ÔÚÏß: 41.8Сʱ
- ³æºÅ: 2576194
- ×¢²á: 2013-08-01
- ÐÔ±ð: GG
- רҵ: É«Æ×·ÖÎö

3Â¥2013-08-02 13:49:46
LT_FU
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 110 (¸ßÖÐÉú)
- ½ð±Ò: 7173.7
- É¢½ð: 156
- ºì»¨: 6
- Ìû×Ó: 1009
- ÔÚÏß: 3099.3Сʱ
- ³æºÅ: 1436839
- ×¢²á: 2011-10-11
- ÐÔ±ð: GG
- רҵ: Á¦Ñ§
4Â¥2013-08-02 13:49:53
landarylau
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 0.6
- É¢½ð: 175
- ºì»¨: 3
- Ìû×Ó: 114
- ÔÚÏß: 25.6Сʱ
- ³æºÅ: 2492298
- ×¢²á: 2013-06-02
- רҵ: Ò©ÀíѧÆäËû¿ÆÑ§ÎÊÌâ
5Â¥2013-08-03 10:19:32
landarylau
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 0.6
- É¢½ð: 175
- ºì»¨: 3
- Ìû×Ó: 114
- ÔÚÏß: 25.6Сʱ
- ³æºÅ: 2492298
- ×¢²á: 2013-06-02
- רҵ: Ò©ÀíѧÆäËû¿ÆÑ§ÎÊÌâ
6Â¥2013-08-03 10:20:36
baiboxie
½ð³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 19 (СѧÉú)
- ½ð±Ò: 12163.5
- É¢½ð: 1588
- ºì»¨: 5
- Ìû×Ó: 3206
- ÔÚÏß: 285.2Сʱ
- ³æºÅ: 209139
- ×¢²á: 2006-03-06
- ÐÔ±ð: GG
- רҵ: ÖÐҩѧ

7Â¥2013-08-03 10:33:33














»Ø¸´´ËÂ¥